You have free access to this content

Hepatology

Cover image for Hepatology

December 2009

Volume 50, Issue 6

Pages 1683–2055, A1–A14

  1. AASLD Position Statement

    1. Top of page
    2. AASLD Position Statement
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    17. Abstracts
    1. You have free access to this content
      Position statement: Nonanesthesiologist administration of propofol for GI endoscopy (pages 1683–1689)

      John J. Vargo, Lawrence B. Cohen, Douglas K. Rex and Paul Y. Kwo

      Version of Record online: 20 NOV 2009 | DOI: 10.1002/hep.23326

  2. Comments from the Editors

    1. Top of page
    2. AASLD Position Statement
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    17. Abstracts
    1. You have free access to this content
  3. Editorials

    1. Top of page
    2. AASLD Position Statement
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    17. Abstracts
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
  4. Viral Hepatitis

    1. Top of page
    2. AASLD Position Statement
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    17. Abstracts
    1. You have free access to this content
      Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin (pages 1702–1708)

      Manuel Romero-Gómez, Moisés Diago, Raúl J. Andrade, José L. Calleja, Javier Salmerón, Conrado M. Fernández-Rodríguez, Ricard Solà, Javier García-Samaniego, Juan M. Herrerías, Manuel De la Mata, Ricardo Moreno-Otero, Óscar Nuñez, Antonio Olveira, Santiago Durán, Ramón Planas and Spanish TRIC-1 (Treatment of Resistance to Insulin in Hepatitis C Genotype 1) group

      Version of Record online: 5 AUG 2009 | DOI: 10.1002/hep.23206

    2. You have free access to this content
      Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus–infected patients (pages 1709–1718)

      Simone Susser, Christoph Welsch, Yalan Wang, Markus Zettler, Francisco S. Domingues, Ursula Karey, Eric Hughes, Robert Ralston, Xiao Tong, Eva Herrmann, Stefan Zeuzem and Christoph Sarrazin

      Version of Record online: 4 AUG 2009 | DOI: 10.1002/hep.23192

    3. You have free access to this content
      Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders (pages 1719–1726)

      Vinod K. Rustgi, William M. Lee, Eric Lawitz, Stuart C. Gordon, Nezam Afdhal, Fred Poordad, Herbert L. Bonkovsky, Leif Bengtsson, Gurudatt Chandorkar, Matthew Harding, Lindsay McNair, Molly Aalyson, John Alam, Robert Kauffman, Shahin Gharakhanian, John G. McHutchison and MErimepodib TRiple cOmbination (METRO) study group

      Version of Record online: 5 AUG 2009 | DOI: 10.1002/hep.23204

    4. You have free access to this content
      Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein (pages 1727–1737)

      Yasuhiro Itsui, Naoya Sakamoto, Sei Kakinuma, Mina Nakagawa, Yuko Sekine-Osajima, Megumi Tasaka-Fujita, Yuki Nishimura-Sakurai, Gouki Suda, Yuko Karakama, Kako Mishima, Machi Yamamoto, Takako Watanabe, Mayumi Ueyama, Yusuke Funaoka, Seishin Azuma and Mamoru Watanabe

      Version of Record online: 5 AUG 2009 | DOI: 10.1002/hep.23195

    5. You have free access to this content
      Fibrosis progression in chronic hepatitis C: Morphometric image analysis in the HALT-C trial (pages 1738–1749)

      Zachary D. Goodman, Anne M. Stoddard, Herbert L. Bonkovsky, Robert J. Fontana, Marc G. Ghany, Timothy R. Morgan, Elizabeth C. Wright, Elizabeth M. Brunt, David E. Kleiner, Mitchell L. Shiffman, Gregory T. Everson, Karen L. Lindsay, Jules L. Dienstag, Chihiro Morishima and HALT-C Trial Group

      Version of Record online: 5 AUG 2009 | DOI: 10.1002/hep.23211

    6. You have free access to this content
      Public health impact of antiviral therapy for hepatitis C in the United States (pages 1750–1755)

      Michael L. Volk, Rachel Tocco, Sameer Saini and Anna S.F. Lok

      Version of Record online: 10 AUG 2009 | DOI: 10.1002/hep.23220

    7. You have free access to this content
      The heat shock protein inhibitor Quercetin attenuates hepatitis C virus production (pages 1756–1764)

      Oscar Gonzalez, Vanessa Fontanes, Santanu Raychaudhuri, Rachel Loo, Joseph Loo, Vaithilingaraja Arumugaswami, Ren Sun, Asim Dasgupta and Samuel W. French

      Version of Record online: 10 AUG 2009 | DOI: 10.1002/hep.23232

    8. You have free access to this content
      High diversity of hepatitis C viral quasispecies is associated with early virological response in patients undergoing antiviral therapy (pages 1765–1772)

      Xiaofeng Fan, Qing Mao, Donghui Zhou, Yang Lu, Jianwei Xing, Yanjuan Xu, Stuart C. Ray and Adrian M. Di Bisceglie

      Version of Record online: 9 SEP 2009 | DOI: 10.1002/hep.23290

    9. You have free access to this content
      Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection (pages 1773–1782)

      Marianna Hösel, Maria Quasdorff, Katja Wiegmann, Dennis Webb, Uta Zedler, Mathias Broxtermann, Raindy Tedjokusumo, Knud Esser, Silke Arzberger, Carsten J. Kirschning, Anja Langenkamp, Christine Falk, Hildegard Büning, Stefan Rose-John and Ulrike Protzer

      Version of Record online: 10 AUG 2009 | DOI: 10.1002/hep.23226

  5. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. AASLD Position Statement
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    17. Abstracts
    1. You have free access to this content
      Reduced expression of ATP7B affected by Wilson disease–causing mutations is rescued by pharmacological folding chaperones 4-phenylbutyrate and curcumin (pages 1783–1795)

      Peter V. E. van den Berghe, Janneke M. Stapelbroek, Elmar Krieger, Prim de Bie, Stan F. J. van de Graaf, Reinoud E. A. de Groot, Ellen van Beurden, Ellen Spijker, Roderick H. J. Houwen, Ruud Berger and Leo W. J. Klomp

      Version of Record online: 5 AUG 2009 | DOI: 10.1002/hep.23209

    2. You have free access to this content
      Maternal high-fat feeding primes steatohepatitis in adult mice offspring, involving mitochondrial dysfunction and altered lipogenesis gene expression (pages 1796–1808)

      Kimberley D. Bruce, Felino R. Cagampang, Marco Argenton, Junlong Zhang, Priya L. Ethirajan, Graham C. Burdge, Adrian C. Bateman, Geraldine F. Clough, Lucilla Poston, Mark A. Hanson, Josie M. McConnell and Christopher D. Byrne

      Version of Record online: 5 AUG 2009 | DOI: 10.1002/hep.23205

    3. You have free access to this content
      Activation of the complement system in human nonalcoholic fatty liver disease (pages 1809–1817)

      Sander S. Rensen, Yanti Slaats, Ann Driessen, Carine J. Peutz-Kootstra, Jeroen Nijhuis, Rudi Steffensen, Jan Willem Greve and Wim A. Buurman

      Version of Record online: 10 AUG 2009 | DOI: 10.1002/hep.23228

    4. You have free access to this content
      Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo-controlled trial (pages 1818–1826)

      Manal F. Abdelmalek, Schuyler O. Sanderson, Paul Angulo, Consuelo Soldevila-Pico, Chen Liu, Joy Peter, Jill Keach, Matt Cave, Theresa Chen, Craig J. McClain and Keith D. Lindor

      Version of Record online: 17 AUG 2009 | DOI: 10.1002/hep.23239

    5. You have free access to this content
      The plasma lipidomic signature of nonalcoholic steatohepatitis (pages 1827–1838)

      Puneet Puri, Michelle M. Wiest, Onpan Cheung, Faridoddin Mirshahi, Carol Sargeant, Hae-Ki Min, Melissa J. Contos, Richard K. Sterling, Michael Fuchs, Huiping Zhou, Steven M. Watkins and Arun J. Sanyal

      Version of Record online: 10 AUG 2009 | DOI: 10.1002/hep.23229

  6. Hepatobiliary Malignancies

    1. Top of page
    2. AASLD Position Statement
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    17. Abstracts
    1. You have free access to this content
      Novel role for epidermal growth factor-like domain 7 in metastasis of human hepatocellular carcinoma (pages 1839–1850)

      Fan Wu, Lian-Yue Yang, Yun-Feng Li, Di-Peng Ou, Dong-Ping Chen and Chun Fan

      Version of Record online: 5 AUG 2009 | DOI: 10.1002/hep.23197

    2. You have free access to this content
      Ikappa B kinaseβ/nuclear factor-κB activation controls the development of liver metastasis by way of interleukin-6 expression (pages 1851–1860)

      Shin Maeda, Yohko Hikiba, Kei Sakamoto, Hayato Nakagawa, Yoshihiro Hirata, Yoku Hayakawa, Ayako Yanai, Keiji Ogura, Michael Karin and Masao Omata

      Version of Record online: 5 AUG 2009 | DOI: 10.1002/hep.23199

    3. You have free access to this content
      Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2 (pages 1861–1870)

      Boris R. A. Blechacz, Rory L. Smoot, Steven F. Bronk, Nathan W. Werneburg, Alphonse E. Sirica and Gregory J. Gores

      Version of Record online: 5 AUG 2009 | DOI: 10.1002/hep.23214

    4. You have free access to this content
      Adenosine triphosphatase pontin is overexpressed in hepatocellular carcinoma and coregulated with reptin through a new posttranslational mechanism (pages 1871–1883)

      Valérie Haurie, Ludovic Ménard, Alexandra Nicou, Christian Touriol, Philippe Metzler, Jérémy Fernandez, Danièle Taras, Patrick Lestienne, Charles Balabaud, Paulette Bioulac-Sage, Hervé Prats, Jessica Zucman-Rossi and Jean Rosenbaum

      Version of Record online: 5 AUG 2009 | DOI: 10.1002/hep.23215

  7. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. AASLD Position Statement
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    17. Abstracts
    1. You have free access to this content
      Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: A population-based study (pages 1884–1892)

      Robert P. Myers, Abdel Aziz M. Shaheen, Andrew Fong, Kelly W. Burak, Alex Wan, Mark G. Swain, Robert J. Hilsden, Lloyd Sutherland and Hude Quan

      Version of Record online: 5 AUG 2009 | DOI: 10.1002/hep.23210

    2. You have free access to this content
      B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-β receptor II dominant negative mice (pages 1893–1903)

      Yuki Moritoki, Zhe-Xiong Lian, Keith Lindor, Joseph Tuscano, Koichi Tsuneyama, Weici Zhang, Yoshiyuki Ueno, Robert Dunn, Marilyn Kehry, Ross L. Coppel, Ian R. Mackay and M. Eric Gershwin

      Version of Record online: 10 AUG 2009 | DOI: 10.1002/hep.23238

    3. You have free access to this content
      Priming of CD4+ T cells by liver sinusoidal endothelial cells induces CD25low forkhead box protein 3 regulatory T cells suppressing autoimmune hepatitis (pages 1904–1913)

      Nils Kruse, Katrin Neumann, Arnhild Schrage, Katja Derkow, Eckart Schott, Ulrike Erben, Anja Kühl, Christoph Loddenkemper, Martin Zeitz, Alf Hamann and Katja Klugewitz

      Version of Record online: 4 AUG 2009 | DOI: 10.1002/hep.23191

  8. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. AASLD Position Statement
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    17. Abstracts
    1. You have free access to this content
      Disruptions of occludin and claudin-5 in brain endothelial cells in vitro and in brains of mice with acute liver failure (pages 1914–1923)

      Feng Chen, Norifumi Ohashi, Wensheng Li, Christopher Eckman and Justin H. Nguyen

      Version of Record online: 5 AUG 2009 | DOI: 10.1002/hep.23203

    2. You have free access to this content
      Role of β3-adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis (pages 1924–1935)

      Jonel Trebicka, Martin Hennenberg, Andrea Schulze Pröbsting, Wim Laleman, Sabine Klein, Michaela Granzow, Frederik Nevens, Johan Zaagsma, Jörg Heller and Tilman Sauerbruch

      Version of Record online: 10 AUG 2009 | DOI: 10.1002/hep.23222

    3. You have free access to this content
      Branched chain amino acids enhance the maturation and function of myeloid dendritic cells ex vivo in patients with advanced cirrhosis (pages 1936–1945)

      Eiji Kakazu, Yoshiyuki Ueno, Yasuteru Kondo, Koji Fukushima, Masaaki Shiina, Jun Inoue, Keiichi Tamai, Masashi Ninomiya and Tooru Shimosegawa

      Version of Record online: 25 AUG 2009 | DOI: 10.1002/hep.23248

  9. Liver Injury/Regeneration

    1. Top of page
    2. AASLD Position Statement
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    17. Abstracts
    1. You have free access to this content
      Cyclin-dependent kinase 1 plays a critical role in DNA replication control during rat liver regeneration (pages 1946–1956)

      Delphine Garnier, Pascal Loyer, Catherine Ribault, Christiane Guguen-Guillouzo and Anne Corlu

      Version of Record online: 10 AUG 2009 | DOI: 10.1002/hep.23225

    2. You have free access to this content
      Variability in the upper limit of normal for serum alanine aminotransferase levels: A statewide study (pages 1957–1962)

      Anand Dutta, Chandan Saha, Cynthia S. Johnson and Naga Chalasani

      Version of Record online: 5 AUG 2009 | DOI: 10.1002/hep.23200

    3. You have free access to this content
      In vivo phosphoenolpyruvate carboxykinase promoter mapping identifies disrupted hormonal synergism as a target of inflammation during sepsis in mice (pages 1963–1971)

      Evgeny Chichelnitskiy, Alexandros Vegiopoulos, Mauricio Berriel Diaz, Anja Ziegler, Anna Kleiman, Alexander Rauch, Jan Tuckermann and Stephan Herzig

      Version of Record online: 4 AUG 2009 | DOI: 10.1002/hep.23194

  10. Liver Biology/Pathobiology

    1. Top of page
    2. AASLD Position Statement
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    17. Abstracts
    1. You have free access to this content
      BH3-only protein bid participates in the Bcl-2 network in healthy liver cells (pages 1972–1980)

      Hayato Hikita, Tetsuo Takehara, Takahiro Kodama, Satoshi Shimizu, Atsushi Hosui, Takuya Miyagi, Tomohide Tatsumi, Hisashi Ishida, Kazuyoshi Ohkawa, Wei Li, Tatsuya Kanto, Naoki Hiramatsu, Lothar Hennighausen, Xiao-Ming Yin and Norio Hayashi

      Version of Record online: 5 AUG 2009 | DOI: 10.1002/hep.23207

    2. You have free access to this content
      Mechanistic insights into immunomodulation by hepatic stellate cells in mice: A critical role of interferon-γ signaling (pages 1981–1991)

      Horng-Ren Yang, Hong-Shuie Chou, Xiaodong Gu, Lianfu Wang, Kathleen E. Brown, John J. Fung, Lina Lu and Shiguang Qian

      Version of Record online: 5 AUG 2009 | DOI: 10.1002/hep.23202

    3. You have free access to this content
      Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload (pages 1992–2000)

      Daniel F. Wallace, Lesa Summerville, Emily M. Crampton, David M. Frazer, Gregory J. Anderson and V. Nathan Subramaniam

      Version of Record online: 12 OCT 2009 | DOI: 10.1002/hep.23198

  11. Rapid Communication

    1. Top of page
    2. AASLD Position Statement
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    17. Abstracts
    1. You have free access to this content
      Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function (pages 2001–2006)

      Christian M. Lange, Jörg Bojunga, Wolf Peter Hofmann, Katrin Wunder, Ulrike Mihm, Stefan Zeuzem and Christoph Sarrazin

      Version of Record online: 29 SEP 2009 | DOI: 10.1002/hep.23346

  12. Reviews

    1. Top of page
    2. AASLD Position Statement
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    17. Abstracts
    1. You have free access to this content
      Epithelial-to-mesenchymal transitions in the liver (pages 2007–2013)

      Steve S. Choi and Anna Mae Diehl

      Version of Record online: 5 AUG 2009 | DOI: 10.1002/hep.23196

    2. You have free access to this content
    3. You have free access to this content
      Severe sepsis in cirrhosis (pages 2022–2033)

      Thierry Gustot, François Durand, Didier Lebrec, Jean-Louis Vincent and Richard Moreau

      Version of Record online: 31 AUG 2009 | DOI: 10.1002/hep.23264

  13. Hepatology Elsewhere

    1. Top of page
    2. AASLD Position Statement
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    17. Abstracts
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
      Shortcut to death (pages 2040–2043)

      Jörn M. Schattenberg and Marcus Schuchmann

      Version of Record online: 20 NOV 2009 | DOI: 10.1002/hep.23400

  14. Image of the Month

    1. Top of page
    2. AASLD Position Statement
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    17. Abstracts
    1. You have free access to this content
      Jaundice after allogeneic hematopoietic stem cell transplantation (pages 2044–2045)

      Manuel Mendizabal, Terina Chen and K. Rajender Reddy

      Version of Record online: 29 SEP 2009 | DOI: 10.1002/hep.23347

  15. Correspondence

    1. Top of page
    2. AASLD Position Statement
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    17. Abstracts
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
      Reply: (page 2048)

      Junfang Ji and Xin Wei Wang

      Version of Record online: 5 OCT 2009 | DOI: 10.1002/hep.23363

    5. You have free access to this content
    6. You have free access to this content
      Reply: (pages 2049–2050)

      Vincent Wai-Sun Wong, Julien Vergniol, Henry Lik-Yuen Chan and Victor de Lédinghen

      Version of Record online: 5 OCT 2009 | DOI: 10.1002/hep.23364

    7. You have free access to this content
    8. You have free access to this content
      Reply: (page 2051)

      Antonio Mazzocca, Salvatore Antonaci and Gianluigi Giannelli

      Version of Record online: 13 OCT 2009 | DOI: 10.1002/hep.23370

    9. You have free access to this content
      Is endoscopic band ligation necessary for primary prophylaxis of esophageal varices without high bleeding risks? (page 2052)

      Seyfettin Köklü, Osman Yuksel, Sahin Coban and Omer Basar

      Version of Record online: 25 SEP 2009 | DOI: 10.1002/hep.23331

    10. You have free access to this content
      Reply: (pages 2052–2053)

      Dhiraj Tripathi and Peter C. Hayes

      Version of Record online: 13 OCT 2009 | DOI: 10.1002/hep.23373

    11. You have free access to this content
      Radiofrequency ablation in patients with hepatocellular carcinoma (page 2053)

      Florence Aslinia and Ayse L. Mindikoglu

      Version of Record online: 29 SEP 2009 | DOI: 10.1002/hep.23342

    12. You have free access to this content
      Reply: (pages 2053–2054)

      Gisele N'Kontchou, Michel Beaugrand and Olivier Seror

      Version of Record online: 13 OCT 2009 | DOI: 10.1002/hep.23375

    13. You have free access to this content
      Metformin, hepatitis C, and insulin resistance: Sufficient evidence? (pages 2054–2055)

      Yusuf Yilmaz, Oya Yonal and Nese Imeryuz

      Version of Record online: 5 OCT 2009 | DOI: 10.1002/hep.23359

    14. You have free access to this content
      Reply: (page 2055)

      Manuel Romero-Gómez, Ana Fernández-Palacín and Conrado M. Fernández-Rodriguez

      Version of Record online: 22 OCT 2009 | DOI: 10.1002/hep.23398

  16. Abstracts

    1. Top of page
    2. AASLD Position Statement
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Hepatology Elsewhere
    15. Image of the Month
    16. Correspondence
    17. Abstracts
    1. You have free access to this content

SEARCH

SEARCH BY CITATION